Research feed
Recently published diabetes studies added to Dediabetes, summarized and organized by intervention and outcome.
Sorted by publication date. Some studies may have been added to Dediabetes later.
The study investigated the effects of tirzepatide on HbA1c levels, highlighting the role of weight loss in these reductions.
This Phase 3 trial evaluated a novel semaglutide injection in Indian adults with Type 2 diabetes, showing significant reductions in HbA1c and body weight.
This study evaluated the effects of sitagliptin on carotid intima-media thickness in type 2 diabetes patients. It found no significant change in IMT but a notable reduction in HbA1c levels.
This study evaluated the addition of glargine, glimepiride, liraglutide, or sitagliptin to metformin in type 2 diabetes. It found varying rates of hypoglycemia among the different treatments.
This study examined the effects of fish oil-derived omega-3 fatty acids on gut microbiota and serum lipid metabolites in individuals with Type 2 Diabetes Mellitus (T2DM). The fish oil group showed significant improvements in various metabolic markers compared to the corn oil control group.
Citrus bioflavonoid-based nutraceutical added to metformin in prediabetic individuals.
This study investigated the effects of multispecies probiotic supplementation on glycemic control in individuals with type 2 diabetes over 24 weeks, finding significant reductions in HbA1c and increases in HDL-c.
L-Citrulline supplementation added to standard treatment in adults with type 2 diabetes.
Magnesium supplementation compared with placebo in adults with type 2 diabetes.
BL21 probiotic added to metformin in adults with type 2 diabetes.
Latest Evidence
Build your workspace to keep track of the latest diabetes research.
